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Abstract
The human asialoglycoprotein (ASGP) receptor, like most other plasma membrane receptors, has
previously been shown to be phosphorylated at serine residues within the cytoplasmic domain. Phorbol
esters, which activate protein kinase C, cause hyperphosphorylation and down-regulation of the ASGP
receptor in HepG2 cells. To test the importance of serine residues for receptor traffic and function, we
have mutated all the cytoplasmic serines of the two receptor subunits H1 (at positions 16 and 37) and H2
(at positions 12, 13, and 55) to alanines or glycines. Stable transfected fibroblast cell lines expressing
either mutant H1 alone or both mutant subunits together were created and compared to cell lines
expressing the respective wild-type proteins. Mutant and wild-type subunits were found to have very
similar distributions between the cell surface and intracellular compartments. Constitutive
internalization of H1 alone and ligand uptake and degradation by cells expressing both receptor subunits
were not affected by the mutations. Cytoplasmic serines and serine phosphorylation are thus not
essential for receptor function and intracellular traffic. Analysis of individual serine mutations identified
serine-12 of subunit H2 as the major site of phosphorylation in the ASGP receptor.
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ABSTRACT The human asialoglycoprotein (ASGP) recep-
tor, like most other plasma membrane receptors, has previ-
ously been shown to be phosphorylated at serine residues within
the cytoplasmic domain. Phorbol esters, which activate protein
kinas C, cause hyperphosphorylation and down-regulation of
the ASGP receptor in HepG2 cells. To test the importance of
serine residues for receptor traffic and function, we have
mutated all the cytoplasmic serines ofthe two receptor subunits
Hi (at positions 16 and 37) and H2 (at positions 12, 13, and 55)
to adanines or glycines. Stable transfected fibroblast cell lines
expressing either mutant Hi alone or both mutant subunits
together were created and compared to cell lines expressing the
respective wild-type proteins. Mutant and wild-type subunits
were found to have very similar distributions between the cell
surface and intracellular compartments. Constitutive internal-
ization ofHi alone and ligand uptake and degradation by cells
expressing both receptor subunits were not affected by the
mutations. Cytoplasmic serines and serine phosphorylation are
thus not essential for receptor function and intracellular traffic.
Analysis of individual serine mutations identified serine-12 of
subunit H2 as the major site of phosphorylation in the ASGP
receptor.
Receptor-mediated endocytosis is the mechanism by which
proteins and other macromolecules of the extracellular me-
dium (e.g., nutrients, hormones, substances to be cleared
from the circulation) are taken up into the cell. Surface
receptors involved in this process are clustered in special-
ized, clathrin-coated regions of the plasma membrane that
invaginate and pinch off as coated vesicles. After removal of
the clathrin coat, they fuse to acidic endosomal compart-
ments where ligand-receptor complexes dissociate. In many
cases the ligands are transported to lysosomes for degrada-
tion, whereas the receptors recycle to the plasma membrane
for reuse (1).
Within such a cycle, receptors are sorted at least at two
points: in the plasma membrane they are concentrated in
coated pits for internalization, and in endosomes they are
collected into tubular extensions for recycling. At least the
first of these sorting processes appears to be mediated by a
signal contained within the receptor structure. Most en-
docytic receptors are single-spanning membrane proteins,
and for several of them, the low density lipoprotein (LDL),
transferrin, polymeric immunoglobulin, and mannose-6-
phosphate receptors, it has been shown that the cytoplasmic
domain is necessary for internalization (2-5). Upon its dele-
tion, these receptors became resident plasma membrane
proteins largely excluded from coated pits. Yet the cytoplas-
mic receptor domains are very diverse in length, orientation,
and primary structure and do not contain any obvious con-
sensus sequences. Individual tyrosine residues have been
shown to be necessary for rapid internalization of the LDL,
the mannose-6-phosphate, the transferrin, and the asialogly-
coprotein (ASGP) receptor (5-8). In addition, other residues
near the tyrosine also appear to be important-e.g., the
sequence Asn-Pro-Xaa-Tyr in the LDL receptor (9).
Another feature common to most endocytic receptors is
phosphorylation of cytoplasmic serine or threonine residues
(10). This modification has been proposed to play an impor-
tant role in regulating intracellular receptor traffic. This
proposal is based on the observation that phorbol esters,
which cause hyperphosphorylation of cell surface receptors
by activating protein kinase C, have a marked effect on the
kinetics of endocytosis of the epidermal growth factor re-
ceptor and the 3-adrenergic receptor (10) and on the intra-
cellular distribution of the transferrin, the ASGP, and the
mannose-6phosphate receptor (11-14).
In this study, we have analyzed the importance of consti-
tutive serine phosphorylation (as opposed to phorbol ester-
induced hyperphosphorylation) and of the cytoplasmic
serines in general for the intracellular traffic of the human
ASGP receptor. This receptor (reviewed in ref. 15) is a
constituent of the plasma membrane of hepatocytes and is
responsible for the clearance of desialylated (galactosyl-
terminal) glycoproteins from the circulation. Serine residues
of the rat and the human ASGP receptor have been shown to
be phosphorylated at steady state (16, 17). After addition of
phorbol esters to HepG2 hepatoma cells, surface ASGP
receptors were rapidly hyperphosphorylated; coordinately
the number of surface receptors was reduced by 40-50% with
a half-time of 20 min, and the majority of phosphorylated
receptors accumulated intracellularly (13, 18, 19). The rate of
internalization and the total number of binding sites were
found not to be affected, but the phosphorylated receptor
population appeared not to be recycled. These findings
suggested that phosphorylation/dephosphorylation might
control receptor traffic, in particular recycling to the cell
surface.
To test this hypothesis, we have mutated the cytoplasmic
serine residues of the two subunits, HI and H2, that consti-
tute the ASGP receptor. After expression of the mutant
subunits in COS-7 cells, we identified the sites of phosphor-
ylation. Mutant subunits lacking any cytoplasmic serines
were stably expressed in fibroblasts and analyzed with re-
spect to their intracellular transport and to receptor function.
MATERIALS AND METHODS
DNA Constructs. Site-directed mutagenesis was performed
according to Kramer et al. (20) or using the kit from Amer-
sham. Hi cDNA (from plasmid pSA1; refs. 21 and 22)
subcloned into phage M13mp9 was used as the template and
the antisense oligonucleotides GTGGTCTCCCTCCTCAT
Abbreviations: ASGP, asialoglycoprotein; ASOR, asialoorosomu-
coid; PBt2, phorbol 12,13-dibutyrate; LDL, low density lipoprotein;
BSA, bovine serum albumin.
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and AGGTCCGGCGCAGAGAC as mismatched primers to
mutate serine-16 to glycine and serine-37 to alanine, respec-
tively (the mismatched nucleotides are underlined). H2
cDNAs were cloned in two differently spliced versions, H2a
and H2b, differing in the presence or absence of five codons
following serine-86 (23). H2b has been shown to account for
=90%6 of H2 mRNA in HepG2 cells (24). A full-length H2b
cDNA was prepared by ligating the complete 5' portion up to
the Nco I site of the full-length H2a cDNA clone pA34 to the
3' portion of the H2b cDNA of clone pA33. The resulting
cDNA was subcloned into M13mpl9 for mutagenesis. The
oligonucleotide GTCTCTGCGCCATGGTCTG was used to
mutate serine-55 to alanine and the degenerate oligonucleo-
tide GCAGCTG(A/I)GC(T/!Q)CGGAGGA to mutate ser-
ine-12 to glycine and/or serine-13 to alanine. Successfully
mutated M13 clones were identified by DNA sequencing.
Cell Culture and Transfection. Cell culture reagents were
purchased from GIBCO. HepG2 and COS-7 cells were grown
in Eagle's minimal essential medium (MEM) with 10%o fetal
bovine serum, and fibroblasts in Dulbecco's modified Eagle's
medium (DMEM) containing 10%1 bovine calf serum (Ino-
tech, Wohlen, Switzerland). The media were supplemented
with L-glutamine (2 mM), penicillin (100 units/ml), and
streptomycin sulfate (100 ,ug/ml). The cell lines 1-7 and 1-7-1
were derived from mouse NIH 3T3 fibroblasts as described
by Shia and Lodish (25). To produce Fi(16/37) cells, the
mutant cDNA ofH1 was subcloned into the retroviral shuttle
vector pLJ (26) and transfected into NIH 3T3 cells according
to Chaney et al. (27). After 2 days, selective medium with
G418 sulfate (1 mg/ml) was added, and after 10-14 days
resistant colonies were cloned and screened for expression
by immunoblot analysis. F1(16/37) cells were further trans-
fected with the mutant H2b cDNA (with all three serine
codons 12, 13, and 55 altered) subcloned into the expression
plasmid pBamHis (a derivative of pLJ with the neomycin-
resistance gene replaced by the his gene of Salmonella; from
R. Mulligan, Whitehead Institute). Resistant cell lines were
selected in medium containing histidinol (2 mg/ml) and were
screened for expression of mutant H2 by immunoprecipita-
tion of cells labeled with [35Slmethionine and [35S]cysteine.
The resulting cell line producing both mutant subunits H1 and
H2 with all five, cytoplasmic serines mutated was called
F1-2(S5). For transient expression, wild-type and mutant
cDNAs were subcloned into pECE (28) and transfected into
COS-7 cells according to Cullen (29). The cells were pro-
cessed after 2-3 days.
Receptor Phosphorylation. For labeling with [32P~phos-
phate, cells were incubated at 370C for 30 min in phosphate-
free medium and then for 60 min in the same medium
supplemented with [32Pjphosphate (Amersham) at 0.5
mCi/ml (1 Ci = 37 GBq). For phorbol ester treatment, 200nM
phorbol 12,13-dibutyrate (PBt2; Sigma) was added for a
further 10-min incubation. The cells were then rinsed with
phosphate-buffered saline (PBS) at 40C and permeabilized
with 0.1% saponin in MEM for 30 min prior to antibody
addition. Subunit-specific rabbit antisera directed against
synthetic oligopeptides corresponding to the carboxyl-
terminal sequence of either the H1 or the H2 subunit were
added at a 1:50 dilution in PBS containing 1 mM phenyl-
methylsulfonyl fluoride (PMSF) and 0.1% bovine serum
albumin (BSA) for 3 hr at 40C. The cells were then lysed in
16
Hi H2N-MTKEYQDLQHLDNEEZpHHQLRK---------------
PBS containing 1% (vol/vol) Triton X-100, 0.5% (wt/vol)
sodium deoxycholate, 2 mM PMSF, 50 mM P-glycerophos-
phate, and 100 ,uM sodium orthovanadate (Sigma). Immune
complexes were precipitated with protein A-Sepharose, dis-
sociated in SDS sample buffer by boiling for 2 min, and
analyzed by SDS/PAGE and autoradiography.
Receptor Distribution. The distribution of the receptor was
determined either by immunoblot analysis of proteinase
K-shaved and untreated cells (30) or by immunoprecipitation
of total and cell surface receptors following metabolic label-
ing. For this, the cells were incubated for 30 min in medium
free ofmethionine and cysteine, then for 30 min with [35S]me-
thionine (150 1uCi/ml) and [355]cysteine (150 ,Ci/ml), and
then for 4 hr with complete medium to allow the labeled
receptor to complete the biosynthetic pathway. The cells
either were left intact or were permeabilized with 0.1%
saponin in DMEM for 30 min at 40C before incubation with
subunit-specific antisera in PBS containing 1% BSA for 2 hr
at 40C. The cells were then washed three times with PBS
containing 1% BSA and solubilized in lysis buffer. The
immune complexes were precipitated with protein A-Seph-
arose and analyzed by SDS/PAGE and fluorography. The
complex glycosylated =46-kDa forms of H1 and H2 were
quantitated by densitometric scanning of the fluorographs.
Assays for Receptor Internalization and for Ligand Uptake
and Degradation. Constitutive internalization of wild-type
and mutant H1 in 1-7 and F1(16/37) cells was analyzed by the
surface iodination and protease protection assay (30). Asialo-
orosomucoid (ASOR) was prepared and iodinated and ligand
binding was performed as described by Shia and Lodish (25),
and ligand uptake and degradation were assessed -according
to Goldstein and Brown (31).
RESULTS
Distribution and Internalization of Subunit 111 Lacking
Cytoplasmic Serine Residues. The ASGP receptor consists of
two homologous subunits, H1 and H2, with 58% sequence
identity (21, 23). They form a heterooligomeric complex that
is necessary for the efficient transport ofboth subunits to the
cell surface and for the formation of high-affinity ligand
binding sites (25). In hepatocytes and HepG2 cells, H1 is 4-5
times more abundant than H2. Recent experiments employ-
ing fluorescence photobleaching recovery suggest a ratio of
three H1 subunits to one or two H2 subunits in the receptor
complex (32).
To assess the role of serine phosphorylation, we mutated
the sefine residues in the cytoplasmic portions of the two
receptor subunits (Fig. 1). Since the major subunit H1 alone
possesses all the signals necessary for constitutive endocy-
tosis and recycling (30), we first analyzed the behavior of a
mutant subunit H1 in which the serines at positions 16 and 37
were changed to glycine and alanine, respectively, in the
absence of H2. Upon site-directed mutation of the corre-
sponding codons, the mutant H1 cDNA was transfected into
mouse 3T3 fibroblasts, and Fi(16/37), a cell line stably
expressing the mutant H1, was isolated. A defect in inter-
nalization or recycling would be expected to cause the
receptor proteins to accumulate either on the cell surface or
intracellularly. The distribution of the receptor protein was
determined by immunoblot analysis of untreated cells and of
37
-GPPPPQPLLQRLCCO GPR...
H2 H2N-MAKDFQDIQQL4JEENDHPFHQGEGPQTRRLNPRRGNPFLKGPPPAQPLAQRLCOMVC...
1213 55
FIG. 1. Amino acid sequences of the cytoplasmic domains ofthe human ASGP receptor subunits H1 and H2. To align homologous segments,
a gap of 18 residues (indicated by dashes) has been inserted in the H1 sequence. Serine residues, which are potential phosphorylation sites, are
circled.
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'ed with proteinase K at 4TC. Approximately 45% of To assess receptor function (i.e., continuous endocytosis
glycosylated mutant H1 was accessible to the pro- of ligand and its delivery to lysosomes for degradation) the
nilarly, in the fibroblast line 1-7, which expresses fibroblast lines expressing wild-type or mutant subunits were
H1, -50%o was found to be on the cell surface (25, incubated at 370C with 125I-labeled ASOR. Cell-associated
Listribution of subunit H1 was thus not significantly '25I-ASOR (Fig. 3, 0) and radioactive degradation products
)y mutation of the two cytoplasmic serines. released into the medium (A) were quantitated. The sum of
:e of constitutive internalization of mutant Hi16/37 these two values (o) corresponds to the cumulative uptake of
ftly determined by the endocytosis assay of Geffen ligand into the cells. Mutant and wild-type receptors dis-
1. The surface of Fi(16/37) and 1-7 cells was first played identical characteristics. Uptake of 125I-ASOR con-
40C with the [1251]iodinated impermeant reagent tinued linearly during the 6 hr of the experiment with a rate
inimidyl 3-(4-hydroxyphenyl)propionate. The cells of 7.4 ligand molecules per surface binding site per hour.
bated at 370C for various times, and the amount of Based on the distribution of the receptor proteins in the two
:d receptor was determined by protease digestion cell lines, there are approximately twice as many total
proteins and immunoprecipitation. The kinetics by cellular binding sites as there are surface binding sites.
d-type and mutant H1 acquired resistance to exog- Accordingly, each receptor complex internalized -3.7 ligand
tease were very similar (Fig. 2). Both the initial rate molecules per hour, independently of whether it was com-
lization and the equilibrium distribution of surface- posed of wild-type or mutant subunits. This value is similar
1 were essentially the same in both cell lines. This to what has previously been reported for 1-7-1 and HepG2
hat the recycling rate is not significantly altered in cells (25, 33). These findings unambiguously show that the
it that is unable to be phosphorylated on serine seine residues in the cytoplasmic portions of the receptor
Clearly, the cytoplasmic serine residues are not subunits are not essential for receptor-mediated endocytosis
for the intracellular transport of subunit H1 alone of ASGP.
Uptake and Degradation by Mutant H1 and He Receptor Phosphorylation in Transfected Fibroblasts. ToUoptakecandDegrToadation by tan im and. characterize the state of phosphorylation of the receptorytoplasmic Serines. To analyze the importance of subunits in transfected fibroblasts (cell lines 1-7 and 1-7-1) and
idues on the trafficking of the functional hetero- (for comparison) HepG2 cells were labeled with [32p]phos-
receptor, F1(16/37) cells were transfected with phate for 1 hr at 37C, incubated for 10 min with or without
Lof H2 in which the codons for the serines at PBt2, and analyzed by immunoprecipitation, gel electropho-
12, 13, and 55 were mutated to codons for glycine resis, and autoradiography (Fig. 4). The receptor proteins in
A stable cell line expressing both subunits H1 and 1-7 and 1-7-1 cells, like those in HepG2 cells, were labeled and
I five cytoplasmic serines mutated, Fl-2(S5), was susceptible to phorbol ester treatment. Both the high-mannose
ts properties were compared with those of 1-7-1 glycosylated precursors of 40 kDa and the complex glycosyl-
roblast line characterized previously (25, 30) that ated mature forms of 46 kDa were phosphorylated, yet PBt2
both wild-type receptor subunits. The distribution treatment affected mainly the mature forms. This is consistent
H2 between the surface and intracellular compart- with the known mode of action of phorbol esters to activate
essentially the same in 1-7-1 and Fl-2(S5) cells: protein kinase C and to induce its association with the plasma
d-type and 44% of mutant H1 and 55% of wild-type membrane (34) and with the previously observed hyperphos-
f mutant H2 were detectable on the cell surface phorylation of the surface receptor pool in HepG2 cells (19).
f three determinations). The mutant subunits as- An important finding is that both in HepG2 and in 1-7-1 cells,
iform high-affinity ligand binding sites: 0.33 pmol subunit H2 incorporated significantly more [32P]phosphate
inding sites per mg of cellular protein was detected than subunit H1, for which phosphorylation could be detected
ace of Fl-2(S5) cells, and 0.45 pmol/mg on 1-7-1 only after PBt2 treatment (Fig. 4, compare lanes 1-4 with lanes
5-8). Since subunit H2 is present in approximately equal
amounts to H1 in 1-7-1 cells (25) and is only about one-third as
abundant as H1 in HepG2 cells, the specific phosphorylation
of subunit H2 is dramatically higher.
Identification of the Phosphorylated Serines. To identify the
sites of receptor phosphorylation, we transfected the cDNAs
of wild-type and mutant subunits into COS-7 cells for tran-
sient expression using the plasmid vector pECE (28). Max-
imal rates of synthesis and accumulation of the proteins were
found at the second day after transfection. The individually
transfected subunits were synthesized as high-mannose gly-
cosylated precursors in COS-7 cells; while H1 readily ma-
tured and accumulated as the complex glycosylated 46-kDa
form, H2 was mostly retained in its precursor form (data not
shown), consistent with previous observations in transfected
fibroblasts (25, 35).
Incorporation of [32P]phosphate into receptor subunits
0 1 0 20 30 40 50 expressed in COS-7 cells after PBt2 treatment is shown in Fig.
Time (min) 5. Wild-type subunit H1 and two mutants in which either
serine-16 was changed to glycine or serine-37 was changed to
ime course of internalization of the mutant H1(16/37) alanine were all labeled (Fig. 5, lanes 1-3), indicating that
HI. The surface of 1-7 and F1(16/37) cells was labeled neither mutation completely abolished phosphorylation.
)succinimidyl 3-(4-hydroxyphenyl)propionate at 4C. Therefore, both serine-16 and serine-37 are targets for phos-
re incubated at 37°C for increasing chase periods (as phorylation. However, the labeling was not detectable with-
ninutes), after which the cells were chilled and surface po n H v th l wa n
digested with proteinase K at 40C. Protease-resistant, out pnoroi ester stimuation tOata not shown). Longer
tor protein was immunoprecipitated and quantitated by labeling times of up to 5 hr did not significantly enhance the
oresis and autoradiography. The mean and standard signal (data not shown), indicating that the low level of
riplicate determinations are shown. [32P]phosphate incorporation was not due to a long-lived
Biochemistry: Geffen et al.
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FIG. 3. Ligand uptake and degradation by 1-7-1 and Fl-2(S5) cells. The cells were incubated at 3TC with '1251-ASOR (2 j.&g/ml) for up to
6 hr. Cell-associated radioactive material (o) and degradation products released into the medium (A) were quantitated and added up to yield the
cumulative ligand uptake (c). The values are expressed as ASOR molecules per surface binding site.
saturating phosphorylation of H1. As in fibroblasts and
HepG2 cells (Fig. 4), labeling of H1 in COS-7 cells was
considerably weaker than labeling of H2.
All possible combinations of serine mutations in subunit
H2 were analyzed whereby serine-12 was changed to glycine,
and the serines at positions 13 and 55 to alanines. None of the
mutants lacking serine-12 was labeled with [32PJphosphate,
while all proteins retaining serine-12 were strongly labeled
(Fig. 5, lanes 4-11). The same result was obtained without
PBt2 treatment (data not shown), indicating that under both
induced and control conditions the same residue was modi-
fied. Clearly, serine-12 is the only site of phosphorylation in
subunit H2.
DISCUSSION
Endocytosis and recycling of plasma membrane receptors
require specific sorting mediated by signals within their
structure. For several endocytic receptors, phosphorylation
of their cytoplasmic domain has been proposed to play such
a role. Many different receptors are phosphorylated at cyto-
plasmic serine or threonine residues by protein kinase C,
which can be activated by phorbol esters. Receptor hyper-
phosphorylation induced by phorbol esters is often tempo-
rally correlated with changes in receptor distribution (10),
suggesting that phosphorylation might be involved in regu-
lating receptor traffic.
In several cases this has indeed been demonstrated. By
site-specific mutagenesis, it has been shown that phosphor-
ylation of threonine-654 of the epidermal growth factor
receptor is necessary for ligand-independent internalization
HepG2 1-7-1 HepG2 1-7
PBt2 +---
: _:46-- -6.
40-- A
;H2 ------Hi
1 2 3 4 5 6 7 8 9 10
FIG. 4. Steady-state and PBt2-induced phosphorylation. HepG2,
1-7-1, and 1-7 cells were labeled with [32P]phosphate for 1 hr and,
after addition of either 200 nM PBt2 (+) or the inactive phorbol ester
4a-phorbol (-), for another 10 min. Receptor proteins were immu-
noprecipitated with antiserum specific for subunit H1 (aHi) or H2
(aH2) and analyzed by SDS/PAGE and autoradiography. The po-
sitions of the 40-kDa precursor and the 46-kDa mature forms are
indicated.
triggered by phorbol esters (36). Similarly, phorbol ester-
induced internalization of the T-cell surface antigen CD4
depends directly on the three serines that are phosphorylated
by protein kinase C (37), and for the polymeric immunoglob-
ulin receptor, serine-664, the single site of phosphorylation,
is required for efficient transcytosis (38). In contrast, the only
phosphorylated residue ofthe transferrin receptor, serine-24,
is not necessary for receptor cycling (3). In addition, muta-
tion of this residue to threonine or alanine did not affect the
phorbol ester-induced receptor redistribution (39, 40), sug-
gesting that there is no causal relationship between transfer-
rin receptor phosphorylation and redistribution.
In this study we have analyzed another recycling transport
receptor, the human ASGP receptor, which consists of two
homologous subunits assembled in a heterooligomeric com-
plex. After transfection into mouse 3T3 fibroblasts, the
subunits were phosphorylated as in HepG2 cells. The major
subunit H1 was labeled only very weakly with [32P]phosphate
unless the cells were treated with phorbol ester. This did not
rule out the possibility that a very short-lived phosphoryl-
ation-e.g., at a distinct step of the endocytic cycle-might
occur. Labeling experiments with transfected COS-7 cells
expressing mutant H1 subunits with individual serines
changed to glycine or alanine revealed that both serine-16 and
serine-37 are potential targets for phosphorylation by protein
kinase C. However, an H1 mutant protein with both cyto-
plasmic serines mutated retained an unchanged distribution
and rate of constitutive internalization when the mutant
cDNA was stably expressed in a fibroblast cell line. This
indicated that serine residues and their phosphorylation are
Hi H2
what 1 6 37 ' +A23 5 '2 '2 '3 ,2
55 55 3
55
N@*gII*
1 2 3 4 5 6 7 8
a
9 10 11
FIG. 5. Identification of the phosphorylated serines. COS-7 cells
expressing the indicated wild-type (wt) or mutant receptor subunits
were labeled with [32P]phosphate for 1 hr and, after addition of 200
nM PBt2, for another 10 min. Receptor proteins were immunopre-
cipitated and analyzed by SDS/PAGE and autoradiography. Similar
amounts of wild-type and mutant subunits were synthesized, as
judged by metabolic labeling and immunoprecipitation from parallel
samples. Filled and open arrowheads indicate the positions of the
mature form of H1 and the precursor form of H2, respectively.
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not necessary for the constitutive cycling of H1 in the
absence of the second subunit.
Subunit H2 was found to be much more highly labeled with
[32P]phosphate than H1. The major site of phosphorylation in
the human ASGP receptor was identified to be serine-12 of
H2. It has been reported (17) that the rat ASGP receptor is
predominantly phosphorylated in its minor subunits 2 and 3
(two differently glycosylated forms of the same gene prod-
uct). While the subunit specificity of phosphorylation ap-
pears to be conserved between the two species, the target
residue is not. In the homologous position 12 of the rat
sequence 2/3, an aspartic acid is found. At least one of the
serines at positions 13, 28, 46, and 55 of the rat sequence 2/3
must be phosphorylated. Interestingly, the sequence context
of serine-12 of H2 does not resemble the typical recognition
sequences for protein kinase C, which are usually preceded
by basic residues (41).
We have generated a fibroblast cell line stably expressing
mutant forms of both receptor subunits H1 and H2 in which
all five cytoplasmic serines were changed. The relative levels
of expression of the two subunits and their intracellular
distribution were very similar to those in 1-7-1 cells, which
express the wild-type proteins. The mutant subunits formed
high-affinity ligand binding sites and supported ligand inter-
nalization at a rate indistinguishable from that of the wild-
type receptor. This result showed unambiguously that cyto-
plasmic serines are not essential for receptor function and
that the phosphorylation of serine residues is not involved in
the mechanism of intracellular receptor transport.
The ASGP receptor thus appears to behave similarly to the
transferrin receptor, which has also been shown to cycle
independently of serine phosphorylation (3, 39, 40). The
ubiquity and specificity of phosphorylation of endocytic
receptors suggest a physiological role for this modification,
which is not clear at present. The human ASGP receptor is
also phosphorylated at tyrosine (42), a modification that has
not been reported for other transport receptors. Tyrosine-5 of
subunit H1 is the only cytoplasmic tyrosine of the ASGP
receptor. The significance of its modification for receptor
function remains to be investigated.
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